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ABSTRACT
Regulated gene expression is essential for a proper
progression through the cell cycle. The transcription
factor NF-Y has a fundamental function in transcrip-
tional regulation of cell cycle genes, particularly
of G2/M genes. In order to investigate common
and distinct functions of NF-Y subunits in cell
cycle regulation, NF-YA, NF-YB and NF-YC have
been silenced by shRNAs in HCT116 cells. NF-YA
loss led to a delay in S-phase progression, DNA
damage and apoptosis: we showed the activation
of the replication checkpoint, through the recruit-
ment of "p53 and of the replication proteins PCNA
and Mcm7 to chromatin. Differently, NF-YB deple-
tion impaired cells from exiting G2/M, but did not
interfere with S-phase progression. Gene expres-
sion analysis of NF-YA and NF-YB inactivated cells
highlighted a common set of hit genes, as well as a
plethora of uncommon genes, unveiling a different
effect of NF-Y subunits loss on NF-Y binding to its
target genes. Chromatin extracts and ChIP analysis
showed that NF-YA depletion was more effect-
ive than NF-YB in hitting NF-Y recruitment to CCA
AT-promoters. Our data suggest a critical role of
NF-Y expression, highlighting that the lack of the
single subunits are differently perceived by the
cells, which activate diverse cell cycle blocks and
signaling pathways.
INTRODUCTION
The histone-like transcription factor NF-Y consists of
three subunits: NF-YA, NF-YB and NF-YC, which are
all necessary for DNA binding of CCAAT boxes (1).
NF-YB and NF-YC evolutionarily conserved core regions
comprise a histone-fold motif, through which they interact
with each other and with NF-YA. While NF-YB and
NF-YC are ubiquitously expressed and their levels are
relatively constant during the different phases of the cell
cycle, NF-YA levels ﬂuctuate throughout the cell cycle
(2,3). Its expression increases at the onset of S phase and
is reduced in IMR-90 ﬁbroblasts after serum deprivation
and in human monocytes (4,5). Although mRNA levels of
NF-YA are relatively constant in growing and dif-
ferentiated cells (2,6), it was recently reported that the
ubiquitin–proteasome pathway and the acetylation status
regulate NF-YA expression and consequently the func-
tional activity of NF-Y (7). NF-YA is expressed as
either a long- or short-form splice variant. The short
isoform lacks 28 amino acids within the glutamine-rich
domain, but maintains the C-terminal NF-YB/NF-YC
interaction and DNA binding domains (8). The expression
levels of the two isoforms vary in different cell types and a
switch in their relative abundance was recently observed
during THE differentiation of mouse ES cells (3,6–9).
The NF-Y complex is a fundamental player in the regu-
lation of cell proliferation, supporting basal transcription
of numerous cell cycle genes (10–12). In silico studies
identiﬁed NF-Y as a common transcription factor asso-
ciated to the regulatory module controlling cell cycle-
dependent transcription of G2/M genes (13,14). In vivo,
chromatin immunoprecipitation (ChIP) experiments
demonstrated that the transcriptional activity of NF-Y
during the cell cycle depends upon its timely regulated
binding to cell cycle promoters (2,12,15). Additionally,
NF-Y plays a pivotal role in the DNA-damage response,
mediating the p53-dependent repression of G2/M genes.
p53 negatively regulates NF-Y activity by decreasing the
Cdk2-dependent phosphorylation of NF-YA. Moreover,
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on multiple CCAAT promoters (16–19).
ChIP on CHIP analysis highlights a bi-functional
activity of NF-Y, which activates or represses transcrip-
tion depending on the cellular and/or chromatin contexts
(20,21). The function of NF-Y in gene transcription and
cell cycle regulation has been investigated by expressing
NF-YA dominant-negative mutants (NF-YA/DN) or by
conditional inactivation of NF-YA. Stable expression of
NF-YA/DN in mouse ﬁbroblasts delays S-phase progres-
sion (22). A truncated NF-YA/Bdbd mutant, lacking the
C-terminal transcription activation domain, leads to cell
cycle arrest speciﬁcally at G2/M without apoptosis (23).
Conditional inactivation of both NF-YA alleles in
primary cultures of mouse embryonic ﬁbroblasts (MEFs)
completely blocks the progression of the cells into S phase
and subsequently leads cells to apoptosis (24).
Our recent analysis of cell cycle progression upon
NF-YB siRNA transfections highlights a different
scenario from NF-YA deletion: NF-YB silenced cells
show a massive delay in G2/M progression and only a
small proportion of cells is impaired in progression to S
phase (25). Microarray and reverse transcription polymer-
ase chain reaction (RT-PCR) data indicate that genes of
G2/M phase are repressed as well as genes for microtu-
bule/cytoskeleton and spindle formation. We demon-
strated that NF-YB knockdown activates p53 and its
pro-apoptotic target genes, in the absence of
DNA-damage.
In this study, we performed cellular and molecular
analysis of HCT116 cells infected with shRNAs to specif-
ically knock down NF-YA, NF-YB or NF-YC. Our data
(i) highlight different phenotypes and transcriptional land-
scapes associated to each subunit silencing and (ii) suggest
that NF-YA expression is fundamental to protect cells
from DNA-damage induced apoptosis.
MATERIALS AND METHODS
Cell lines
The human colon carcinoma HCT116 and HCT116 p53
/
were generously provided by Bert Volgestein (Johns
Hopkins University School of Medicine, Baltimore,
MD). The cells were maintained as previously described
(18,25,26). Human cervical carcinoma Hela and human
colorectal carcinoma LoVo cell lines were maintained in
DMEM supplemented with 10% FBS.
Short hairpin RNA
pLKO.1 non-target short hairpin RNA (shRNA)
(SHC002), shRNA-NF-YA, targeting exon 6 (CCATCG
TCTATCAACCAGTTA), shRNA-NF-YB targeting ex 5
(GCTATGTCTACTTTAGGCTTT) and shNF-YC tar-
geting exon 5 (GCCTGGATTCACACAGAAGAT)
were designed by Sigma-Aldrich. Puromycin resistance
cassette was replaced with EGFP cassette. For lentivirus
production, the shRNA vector plasmid (20mg) and
second-generation packaging plasmids (5mg of pMD2-
VSVG and 15mg of pCMVR8.91) were cotransfected
into HEK293T cells. Lentivirus-containing supernatant
was collected 24h after transfection, centrifuged at
3000rpm to remove cell debris for 5min, 0.45mm-ﬁltered
and frozen at 80C until use. The titer of lentiviral
shRNA particles was determined by use of Fluorescent
Activated Cell Sorter (FACS) counting of transduced
GFP-positive cells. HCT116 cells were infected by
spinoculation (1800rpm for 45min at 30C) at MOI5.
Forty-eight hours post-infection cells were harvested for
cell cycle analysis, total extracts and RNA extraction.
Flow cytometric cell cycle analysis
Cells were harvested after shRNA infection and DNA dis-
tribution analysis of Propidium-Iodide-stained cells was
performed by an Epics cytoﬂuorimeter (Beckman
Coulter). Apoptotic cells were identiﬁed by FACS using
Annexin V-FITC conjugate (Bender MedSystems) follow-
ing the protocol of the manufacturer. Replicative DNA
content was analyzed using bivariate ﬂow cytometry.
Cells were pulsed with 20mM BrdU for 30min at 37C.
After washing with PBS1/Tween-20 0.5%, cells were
treated with 2N HCl for 30min at room temperature,
followed by the addition of 0.1M borate buffer, pH 8.5.
Cells were washed and incubated with mouse anti-BrdU
antibody (#317902 BioLegend) for 1h at 4C. After
washing, cells were incubated with FITC anti-mouse
(#F0313 Dako) for 1h at 4C. Finally, cells were
counter stained with PI solution (propidium iodide
25mg/ml, Na–Citrate 3.4mM, NaCl 9.65mM, NP-40
0.03%) for 15min, and then analyzed by cytoﬂuorimeter.
Indirect ﬂuorescence staining was performed using
anti-phospho H2A.X (Upstate #05-636) and mouse
anti-FITC (#F0313 Dako). Brieﬂy, cells were harvested,
washed twice with PBS 1, ﬁxed in 1% formaldehyde for
10min at 37C, and post-ﬁxed with 90% ethanol. After
permeabilization with 0.25% Triton X-100 in PBS 1 for
5min, cells were stained with primary antibody (1:25) o.n.
at 4C, and secondary antibody (1:50) for additional 2h
at 4C. Cells were then treated with RNAse A for 40min,
incubated with propidium iodide (30mg/ml) for additional
30min at 4C in the dark and analyzed with cytometer.
Immunoblotting
Total extracts were prepared by resuspending the cell
pellet in lysis buffer (50mM Tris–HCl pH 8.0, 120mM
NaCl, 0.5% NP-40, 1mM EDTA, protease and phosphat-
ase inhibitors). Chromatin enriched extracts were prepared
as described by Mendez and Stillman (27). For immuno-
blotting, an equivalent amount of cellular extracts were re-
solved by SDS–PAGE, electrotransferred to PVDF
membrane, and immunoblotted with the following anti-
bodies 1:1000 in TBS1X-BSA 1mg/ml: anti-NF-YA
(sc-10779 Santa-Cruz), anti-NF-YB (Pab 001 GeneSpin),
anti-p53 DO-1 (sc-126 Santa Cruz), anti-phospho H2A.X
(clone JBW301) (#05-636 Millipore), anti-phospho-p53
(Ser15) (#9284 Cell Signaling), anti-CycB1 (V152)
(GTX72347 Genetex), anti-cleaved Casp7 and Casp9 (#9491
and #9501 Cell Signaling), anti-PARP1 (sc-8007 Santa Cruz),
anti-PCNA (sc-56 Santa Cruz), anti-Mcm7 (sc-9966 Santa
Cruz), anti-H2A (#39111 Active Motif), anti-Cdc6 (sc-9964
Santa Cruz), anti-Cdt1 (sc-28262 Santa Cruz),
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anti-tubulin (T6074 Sigma Aldrich) and anti-actin (I-19)
(sc-1616 Santa Cruz).
RT-PCR analysis
RNA was extracted using the RNeasy kit (Qiagen, Hilden,
Germany), according to the manufacturer’s protocol,
from HCT116 infected cells. For cDNA synthesis, 3mg
of RNA was retrotranscribed with a Moloney murine
leukemia virus reverse transcriptase (Finzymes).
Semiquantitative PCRs were performed in a linear range
of each ampliﬁcation product. PCR oligonucleotides were
previously described (25) or listed in Supplementary Data.
ChIP
Chip were performed as previously described (18,25,26).
Chromatin was prepared upon 48h shCTR, shNF-YA
and sh-NF-YB infection. Quantitative real time PCR
was performed using SYBR green IQ reagent (Biorad) in
the iCycler machine (Biorad). Primers were designed to
amplify genomic regions of 100–150-bp size. The relative
sample enrichment was calculated with the following
formula: 2
Ctx2
Ctb, where Ctx=Ct inputCt
sample and Ctb=Ct inputCt control Ab.
Gene expression proﬁling and data analysis
Total cellular RNAs from HCT116 cells were isolated
using RNeasy Kit (Qiagen, Germany) from shRNA
infected cells. For each sample, 500ng of total RNA
were synthesized to biotinylated cRNA using the
Illumina RNA Ampliﬁcation Kit (Ambion Inc., Austin,
TX, USA). Synthesis, HumanHT12 v 3.0 Expression
BeadChip ILLUMINA arrays hybridization (Illumina
Inc., San Diego, CA, USA), staining and scanning were
performed according to the standard protocol supplied by
Illumina.
For data analysis, the intensity ﬁles were loaded into the
Illumina BeadStudio v. 3.1.3.0 software for quality control
and gene expression analysis. First, the quantile normal-
ization algorithm was applied on the data set to correct
systematic errors. Background was subtracted. For differ-
ential expression analysis, technical replicates of each
sample were grouped together and genes with a detection
of P-value<0.01, corresponding to a false-positive rate of
1%, were considered as detected. Differently expressed
genes were selected with differential score cutoff set at
±40 and genes with fold difference <1.5 or >1.5 were
further analyzed (Supplementary Tables S1 and S2).
Gene Ontology (GO) enrichment P-values were computed
according to the hypergeometric distribution (28). Only
terms with P<1.00E-05 GO were displayed and the
terms have been ranked by decreasing P-value.
RESULTS
NF-Y subunits inactivation results in decreased
proliferation
To understand the biological functions of NF-Y subunits,
we knocked down the expression of NF-YA and NF-YB
in HCT116 cells by lentiviral delivery of shRNAs. A
non-target shRNA was used as control vector (shCTR).
Of the ﬁve different shRNAs tested for NF-YA and
NF-YB inactivation, we selected shNF-YA targeting
exon 6 and sh-NF-YB targeting exon 5 (Figure 1A).
Expression levels of NF-Y subunits were conﬁrmed by
western blot and RT-PCR analysis: NF-YA and NF-YB
were completely depleted by 48h after infection with
shRNAs (Figure 1B). We noted that NF-Y inactivated
cells grew more slowly than control cells, particularly a
high percentage of cell death was observed in cell culture
medium upon shNF-YA infection. The effect on cell pro-
liferation was investigated through the estimation of
growth rate. At 48h post-infection, cells were trypsinized
and equal numbers of cells were seeded into new culture
dishes. Cell growth was signiﬁcantly suppressed at 12, 24,
48 and 72h post-seeding in NF-Y inactivated cells, par-
ticularly upon NF-YA loss (Figure 1C, left panel).
Western blot showed the stability of NF-YA and
NF-YB knock-down up to 72h post-seeding (Figure 1C,
right panel).
Figure 1. (A) shRNAs were designed on human NF-YA and NF-YB
genes, targeting exons 6 and 5, respectively (arrows). (B) Transcription
(left panel) and protein levels (right panel) of NF-YA and NF-YB
subunits after 48h of shRNA lentiviral infection of HCT116 cells.
(C) Left panel: growth rate of control and shRNA-infected HCT116
cells. Forty eight hours post-infection cells were trypsinized and equal
number of cells were seeded into new culture dishes (time= 0h). Viable
cells were estimated after 12, 24, 48 and 72h post-seeding. Right panel:
western blot analysis of total extracts of control and shRNA infected
cells. Actin was used as loading control.
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The reduced cell doublings in NF-Y inactivated popula-
tions could be due to apoptosis, cell cycle arrest, or both.
To discriminate between these two possibilities, we per-
formed a PI-cytometric analysis of the cells at 48h post-
infection (Figure 2A, left panel). The relative content of
DNA indicated that the distribution of cells throughout
the cell cycle was differently affected by NF-YA or
NF-YB silencing. An increase of cells with an sub-G1
DNA content was observed only after shNF-YA (24%
upon NF-YA and 5% upon NF-YB inactivation versus
4% in control cells). Compared to shCTR, shNF-YA ex-
pression increased S phase (from 7.6% to 15.5%), while
G1 events decreased. NF-YB knock-down induced only a
slight increase of G2/M population (from 16% to 23%).
Although no sub-G1 events were detected upon 48h
from shNF-YB infection, cytoﬂuorimetric analysis
revealed an increase of apoptotic AnnexinV-positive cells
(Figure 2A, left panel). Indeed, albeit to a lesser degree
compared to shNF-YA, 72h post-infection also in
shNF-YB cells we identiﬁed sub-G1 events (from 2% in
control cells to 11% in shNF-YB cells) (Figure 2A, right
panel). Moreover, we observed that apoptosis activation
was concurrent to a slight decrease of the G2/M popula-
tion (from 28% in shCTR cells to 23% in shNF-YB cells),
reproducing a phenotype similar to siRNA-mediated
NF-YB silencing (25).
The signiﬁcant increase of apoptotic cells upon 48h
from infection of shNF-YA was not ascribable to a dif-
ferent level of knock-down compared to shNF-YB. Dose–
response experiments were performed with shNF-YA and
shNF-YB: after 48h, although at higher doses of MOI, no
sub-G1 events were detected in shNF-YB cells.
Conversely, shNF-YA cells underwent apoptosis despite a
residual NF-YA expression (Supplementary Figure S1A).
A similar alteration of the cell cycle was observed after
NF-YA and NF-YB silencing in p53-positive human colo-
rectal carcinoma LoVo cells (data not shown).
Interestingly, sub-G1 events also raised upon NF-YA
knock-down in cervical carcinoma Hela cells, in which p53
is degraded by E6 espression (from 10% in shCTR to 35%
in shNF-YA cells) (Supplementary Figure S1B, left panel).
This result can be ascribed to the restored expression of p53
in shNF-YA cells, as demonstrated by western blot
analysis (Supplementary Figure S1B, right panel). As
observed for HCT116 cells, a G2/M increase was evident
only in shNF-YB cells (from 11% to 20%).
As the histone-fold NF-YC subunit dimerizes with
NF-YB and shares the activation domain with NF-YA,
we wondered which cell cycle effect could be triggered by
silencing NF-YC. At 48h from the infection, the inactiva-
tion of all the decribed NF-YC isoforms (29) led to a slight
increase of G2/M population and Annexin-V positive
cells, without accumulating sub-G1 events
(Supplementary Figure S1C), similarly to shNF-YB cells
(Figure 2A).
The detection of a DNA ladder pattern highlighted that
late stages of apoptosis occurred upon NF-YA loss
(Figure 2B, left panel). Moreover, NF-YA depletion
resulted in the activation of caspases, among which
caspase 9 and 7, which triggered the proteolytic cleav-
age of PARP1 (Figure 2B, right panel and Supplementary
Figure S1B).
The progression through the different phases of the cell
cycle was analyzed in asynchronous cells by bivariate
FACS analysis (Figure 2C). Compared to control cells,
we detected an increase of G2/M events both in
shNF-YA and shNF-YB cells (from 15% to 23.8% and
24.9%, respectively). NF-YA inactivation didn’t result in
any change of replicative events, although monopara-
metric analysis showed the doubling of cells in S phase
(Figure 2A). This inconsistency could be explained by
the increase of BrdU negative cells with an S-phase
DNA content (S2), not observed in shCTR and shNF-
YB cells (from 2% in shCTR and shNF-YB to 12% in
shNF-YA cells). The S2 population could represent
non-cycling S cells.
It has been reported that H2AX is phosphorylated
(gH2AX) during apoptotic DNA fragmentation in
mouse and human cells (30,31). Aditionally, gH2AX is a
well-known marker of DNA damage, whose recruitment
at DNA damaged sites seems to be fundamental for an
efﬁcient DNA repair (32,33). To discriminate between
these two possibilities, apoptosis induced by NF-YA loss
was inhibited by pre-treating cells with the pan-caspase
inhibitor ZVAD. Although the percentage of apoptotic
cells was completely abolished, H2AX phosphorylation
was reduced but still sharp (Figure 2D, upper panel).
Interestingly, the inhibition of apoptosis strongly incr-
eased the percentage of S2 cells from 12% to 40%
(Figure 2D, lower panel).
These results suggested that S2 cells are addressed to
apoptosis and that gH2AX activation is likely associated
to DNA damage, triggered by NF-YA loss.
Replication defects are associated to NF-YA loss
Cell cycle progression was studied in synchronous popu-
lations. Infected HCT116 cells were starved in serum-free
for 30h and then released in 10% FCS. The cells were
harvested at different times and bivariate FACS analysis
was performed (Figure 3A). At time 0h, 85% of shCTR
and 78% of shNF-YA cells were in G0/G1 phase. The
proportion of cells passing through S phase was
normalized to starting G0 cells. No relevant differences
could be detected between control and shNF-YA cells
up to 14h, when BrdU-positive cells were mainly
retained in early-S (55% in early-S and 34% in late-S in
shCTR, and 57% in early-S and 28% in late-S in
shNF-YA cells). Conversely, after 18h, a dissimilarity
was observed in the distribution of BrdU-positive cells.
Control cells were mainly accumulated in late-S (15% of
cells in early-S and 30% in late-S) and a G2/M increase
was clearly observed. Following NF-YA inactivation,
BrdU-positive cells were equally distributed between
early and late-S (27% both in early- and late-S).
Consequently, fewer cells entered the G2/M phase at
18h compared to shCTR cells (24% in shNF-YA and
35% in shCTR cells). Moreover, it was evident the
increase of the S2 population (from 1% of control cells
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course increase of cyclinB1 expression in control cells,
clearly impaired upon NF-YA inactivation (Figure 3B).
As to NF-YB inactivation, although serum deprivation,
at time 0h a signiﬁcant percentage of cells was still
retained in G2/M (15% compared to 5% of shCTR
cells). When normalized to the starting G0 population,
cells were only slightly delayed in entering the early S
phase. Once entered, shNF-YB cells were not slowed
down in passing to late S and G2/M. The kinetics of cell
cycle progression was further supported by a reduced but
still consistent expression of cyclinB1. Lower levels of
cyclinB1 were expected, considering that few NF-Y mol-
ecules can still transactivate the CCNB1 CCAAT-gene.
The effect of NF-Y abrogation on DNA replication was
investigated by BrdU pulse-chase experiments on
synchronized G0 cells. After 10h from the release,
shNF-YA and shNF-YB cells were pulsed with BrdU
for 30min, after which the BrdU was washed away and
the cells were allowed to grow in normal medium for dif-
ferent time points. We followed the BrdU-positive cells as
they passed through S (Figure 3C, blue dots), G2/M and
Figure 2. (A) PI/monoparametric FACS analysis of HCT116 cells after 48h of infection with shCTR, shNF-YA and shNF-YB (left panel) and 72h
of infection with shCTR and shNF-YB (right panel). The percentage of Annexin V-positive cells is indicated under each panel. (B) Left panel: DNA
agarose gel electrophoresis showing the typical DNA ladder pattern of apoptosis after 48h of shNF-YA infection. Right panel: expression analysis of
cleaved caspase 7 and 9 and PARP1 in NF-YA or NF-YB silenced cells. (C) BrdU/PI cytoﬂuorimetric analysis of HCT116 cells 48h post-infection
with shRNAs. Red dots represent BrdU-positive cells. (D) Left panel: PI (upper panel) and BrdU/PI (lower panel) cytoﬂurimetric analysis of NF-YA
inactivated cells untreated or treated with the pan-caspase inhibitor ZVAD. Blue dots represent non-cycling S cells (S2). Right panel: NF-YA and
gH2AX expression analysis of total extracts of shCTR and shNF-YA cells, untreated or treated with ZVAD. Actin was used as loading control.
5360 Nucleic Acids Research, 2011,Vol.39, No. 13returned to G1 phase (red dots). shCTR BrdU-positive
cells completed S phase in 6–8h (from 10 to 16–18h)
and clearly entered the G2 phase at 16h, growing to
90% at time 18h (Figure 3C, ﬁrst panel t=18h,
arrow). At 20h, 25% of cells moved to next G1 phase
(last panel t=20h, arrow). Upon NF-YA inactivation, it
was evident that more than 30% of cells were still in
S phase at 20h (middle panel, blue dots) and fewer cells
reached the G2/M and entered the next G1 phase. The
duration of S phase upon NF-YB inactivation was
similar to shCTR (Figure 3C, third panel). The main
defect observed was associated to the prolonged G2/M,
Figure 3. (A) Time-course BrdU/PI cytoﬂuorimetric analysis at time 0, 8, 10, 14 and 18h post-release from serum starvation of shRNA infected
cells. (B) CyclinB1 expression analysis of total extracts of shCTR, shNF-YA and shNF-YB cells at the indicated times after release from serum
starvation. Tubulin was used as loading control. (C) BrdU pulse-chase biparametric FACS analysis of synchronized G0 cells upon NF-YA and
NF-YB inactivation versus control cells.
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G1 at 20h (from 25% in shCTR to 12% in shNF-YB).
These results suggest that NF-Y could have an import-
ant role in DNA replication and G2/M progression.
NF-YA-induced DNA-damage and p53 activation are
coupled with S-phase defects
gH2AX staining upon NF-YA inactivation was main-
tained although apoptosis inhibition (Figure 2D). It is
possible that H2AX phosphorylation is an indication of
early DNA-damage that culminates in the S-phase arrest.
To investigate this hypothesis, we analyzed gH2AX
staining in shNF-YA cells released from serum starvation
(Supplementary Figure S2A). gH2AX quantiﬁcation
respect to total H2A highlighted a sharp increase at 16
and 18h from the release, corresponding to defects in
cell cycle progression (Figure 3A). Bivariate distributions
representing cellular DNA content versus gH2AX of asyn-
chronous shNF-YA cells showed both 2N and 4N gH2AX
positive cells (Supplementary Figure S2B). These data hint
that DNA damage doesn’t occur uniquely in S population,
although it is possible that S damaged cells are more prone
to apoptosis (Figure 2D). In response to DNA damage,
H2AX has been reported to be phosphorylated by ATM,
ATR, which is mainly associated to replication stress (34),
as well as DNA-PK, observed during apoptotic DNA
fragmentation (30). To inhibit ATM/ATR activation, we
co-treated shNF-YA cells with non-toxic dose of caffeine
(1mM) and we analyzed cell cycle distribution by cytoﬂu-
orimetric analysis (Supplementary Figure S2C). Caffeine
didn’t completely inhibit apoptosis, but decreased the per-
centage of sub-G1 cells of 25% (from 40% without
caffeine to 30% upon caffeine treatment), suggesting the
contribution of ATM/ATR to apoptosis activation.
One of the main signal transducer of DNA damage is
p53. Western blot analysis of shCTR extracts highlighted
a slight p53 expression, which increased after NF-Y deple-
tion (Figure 4A, left and middle panels). As shown in
Figure 4A (right panel), a less severe activation of apop-
tosis was observed upon NF-YA loss in HCT116 p53
/
cells (from 2.8% in shCTR to 11% in shNF-YA cells),
hinting that p53 plays a role in apoptosis induced in
shNF-YA cells.
We then checked for p53 phosphorylation at Ser15, a
critical event in its activation following DNA-damage.
Ser15-p53 phosphorylation was observed in HCT116
shNF-YA cells (Figure 4A, left panel). ATM and ATR
directly phosphorylate p53 on Ser15 and activate other
kinases, such as Chk1, Chk2 and Plk3, which in turn me-
diate the phosphorylation of p53 on additional residues.
Western blot analysis of phospho-Chk2 (Thr68) showed
its overexpression upon NF-YA loss (Supplementary
Figure S2C, right panel).
In addition to its post-translational modiﬁcations, it
was reported that alternative splicing of p53 has a role
in promoter selectivity of target genes. In particular, a
novel human p53 isoform (p53) has been found to be
associated to intra-S checkpoint activation (35). Western
blot analysis in HCT116 cells with DO-1 antibody,
recognizing the N-terminus domain of p53, detected a
lower migrating p53 isoform, whose molecular weight is
consistent with p53. A slight increase of p53 was
observed in shNF-YA cells, both as protein and mRNA
levels (Figure 4A, left and middle panels). While Rohaly
et al. showed p53 binding to DNA in damaged S-phase
cells (35), Chan et al. (36) demonstrated that p53 is
excluded from the nucleus, due to the deletion of a
nuclear localization signal, and only slightly accumulated
in the nucleus when it is coexpressed with p53.
Chromatin-enriched extracts showed p53 accumulation
after NF-YA silencing, corroborating its possible activity
in the attenuation of S phase progression (Figure 4B, left
panel). Differential enriched extracts from HCT116 cells
transiently transfected with p53 showed that its
overexpression led to both cytoplasmic and nuclear local-
ization in this cellular context (Figure 4B, right panel),
consistently with its possible recruitment to chromatin.
In addition, higher levels of chromatin-bound PCNA
and of the replication helicase Mcm7 were found in
shNF-YA cells, compared to shCTR and shNF-YB
cells. Conversely, Cdt1 and Cdc6, which are required
for the assembly of the pre-RC and loading of the
MCM complex, didn’t increase their expression levels
(Figure 4B). Besides its role in the initiation of DNA rep-
lication, PCNA has been demonstrated to be an important
component of multiple DNA repair (37), while an excess
of Mcm2-7 is required for human cells to survive replica-
tive stress (38). These data suggested that NF-YA loss can
trigger the activation of the S-checkpoint, differently from
NF-YB abrogation.
As expected, the amount of both NF-YA and NF-YB
associated with chromatin decreased upon NF-Y subunits
inactivation (Figure 4B, left panel). Interestingly, NF-YA
depletion was more efﬁcacious in hitting NF-Y binding to
DNA than NF-YB loss. To better investigate NF-Y
chromatin-recruitment, we performed ChIP assays with
anti-NF-YA and anti-NF-YB antibodies (Figure 4C).
Real-time qPCR further supported the hypothesis that
NF-YA inactivation impaired NF-Y recruitment on CC
AAT-promoters more strongly than NF-YB depletion.
Changes in gene expression upon NF-YA and NF-YB
silencing
Expression proﬁling analysis of NF-Y inactivated cells
was performed with the Illumina platform, which targets
more than 37000 annotated genes. Using relatively strin-
gent criteria and employing the hypergeometric distribu-
tion to compute an enrichment P-value, we found that in
shNF-YA cells 1195 and 1412 genes were up- and
down-regulated, respectively, while transcription levels of
only 515 and 685 genes increased and decreased following
NF-YB depletion (Supplementary Tables S1 and S2). GO
enrichment analysis of the shNF-YA repressed genes iden-
tiﬁed metabolic process as the statistically most important
term retrieved (Figure 5A). No functional categories with
P-value<1.00E05 were found among shNF-YA
up-regulated genes. Conversely, NF-YB repressed genes
were statistically retrieved in cell cycle, microtubule/
cytoskeleton and DNA-metabolism functions, as already
observed upon NF-YB siRNA transfection (25). NF-YB
5362 Nucleic Acids Research, 2011,Vol.39, No. 13inactivation led to the up-regulation of relatively few GO
terms, among which were those of lipid and sterol metab-
olism: this is somewhat surprising, since NF-Y is known
to cooperate with SREBP1 and SREBP2 to activate many
of these genes (39,40).
Promoter sequences of genes differentially expressed
were analyzed with the Pscan algorithm (41) using the
new NF-Y-PSFM matrix (positional sequence frequency
matrix) (42), to identify whether the NF-Y binding site
motif was over-represented in shNF-Y modulated genes.
The CCAAT box showed a signiﬁcant enrichment with
P-value 4.91E13 and 7.76E19 in promoter sets of
genes down-regulated after NF-YA or NF-YB loss, re-
spectively. This analysis conﬁrmed the direct involvement
of NF-Y in the transcriptional regulation of down-
regulated sets of genes. On the other hand, the CCAAT
module was not enriched in up-regulated genes, suggesting
an indirect effect.
Figure 4. (A) Left panel: p53, Phospho-Ser15 p53 and p53 expression analysis of HCT116 total extracts 48h post-infection. Actin was used as
loading control. Middle panel: RT-PCR analysis of p53 and p53 mRNA transcripts. Right panel: monoparametric cell cycle analysis of HCT116
p53
/ cells after shCTR and shNF-YA infection for 48h. (B) Left panel: expression analysis of chromatin enriched extracts with the indicated
antibodies. Right panel: p53 and p53 expresison analysis of cytoplasmic and nuclear extracts from HCT116 cells transiently transfected with p53
and p53-Flag. (C) ChIP analysis of NF-Y binding to the indicated CCAAT-promoters in shCTR, shNF-YA and shNF-YB cells. The enrichment
was calculated as percentage IP recovery (%IP) of NF-YA and NF-YB over input normalized to satellite DNA. The input signal consists of 20% of
the amount of chromatin used with each immunoprecipitation.
Nucleic Acids Research, 2011,Vol.39, No. 13 5363Semiquantitative and real time RT-PCRs were per-
formed to validate the proﬁling analysis (Figure 6A and
Supplementary Figure S3). With the exclusion of POLE2
and RPA1, predicted to be unmodiﬁed and up-regulated
upon NF-YA loss, respectively, and MCM4, predicted to
be down-regulated in shNF-YB cells, qRT-PCR analysis
matched with the microarray proﬁles. The NF-Y matrix
(42) and the Pscan algorithm (41) were used to scan the
promoters sequence of these possible NF-Y targets. The C
CAAT scores give an estimate of the likelihood of the
sequences to represent a site recognized by NF-Y
(Figure 6A, right panel). To investigate the binding of
NF-Y to the predicted target genes, ChIP analysis was
performed with anti NF-YA and NF-YB antibodies in
HCT116 cells. As showed in Figure 6B, NF-Y was
bound to 13 of the 16 analyzed genes, suggesting that
NF-Y is directly involved in their transcriptional regula-
tion. CCNB1 promoter, a well-known NF-Y target, was
used as positive control (Figure 6B).
By real time RT-PCR we further analyzed cell cycle
G2/M CCAAT-regulated genes, which were retrieved as
down-regulated genes only upon NF-YB loss. As shown
Figure 5. (A) Gene Ontology (GO) terms displaying a statistically signiﬁcant over-representation in the sample sets (down- and up-regulated)
retrieved from microarray expression analysis of NF-YA and NF-YB silenced versus shCTR cells. Terms have been pruned and grouped according
to manually determined macro-categories identiﬁed by different colors. (B) mRNA expression analysis of CCNB1, CCNB2, Cdc25C and Cdc2 by
real time RT-PCR. mRNA transcripts have been normalized versus TBP and b-actin expression levels.
5364 Nucleic Acids Research, 2011,Vol.39, No. 13in Figure 5B, both NF-YA and NF-YB inactivation led to
CCNB1, CCNB2, Cdc25C and Cdc2 transcriptional
decrease. Changes in gene expression correlated with
decreased recruitment of NF-Y on gene regulatory
regions observed by ChIP analysis (Figure 4C).
Thus, although NF-YA loss impaired the transcription
of a wide panel of CCAAT-genes, the metabolic regula-
tory genes might be mainly affected. Alterations in gene
expression of these genes could likely contribute to trigger
apoptosis.
DISCUSSION
The role of NF-Y in controlling cell growth and apoptosis
has been mainly attributed to its activity in gene
transcription. We previously demonstrated that transient
NF-YB inactivation by siRNA led to a delay in G2/M
transition induced by the down-regulation of G2/M CC
AAT-genes (25). To dissect various functions of NF-Y
subunits in vivo, we have utilized shRNAs targeting
NF-YA, NF-YB and NF-YC in HCT116 cells. The com-
parison between the two subunits inactivation has led to
new insights into the function of NF-Y into the cell.
The estimation of growth rate of NF-YA and NF-YB
inactivated cells (Figure 1) has questioned the role of the
two subunits in the cell cycle. Although NF-Y transcrip-
tional activity needs the association of all the subunits, our
data suggest that each NF-Y component could have
speciﬁc functions. Interestingly, western blot analysis
highlighted that NF-YA depletion affects the expression
Figure 6. (A) Semiquantitive RT-PCR validation of the proﬁling analysis of the indicated transcripts after NF-YA and NF-YB silencing compared
to control cells. mRNA transcripts have been normalized versus MLL1 expression levels. The predicted changes of the expression levels from
Illumina platform (up, down or unchanged), the Ref Seq ID and the estimated CCAAT score are indicated in the table. (B) ChIP analysis of NF-YA
and NF-YB binding to the indicated genes in HCT116 cells. The enrichment was calculated as percentage IP recovery (%IP) of NF-YA and NF-YB
over input normalized to satellite DNA.
Nucleic Acids Research, 2011,Vol.39, No. 13 5365of NF-YB subunit (Figure 1). It is possible that NF-YA
and the stable heterodimer NF-YB/NF-YC could have
distinct functions in the cell. This hypothesis is further
supported by the results gained by NF-YC inactivation
(Supplementary Figure S1C), showing an effect on the
cell cycle comparable to NF-YB loss.
Silencing NF-YA expression affects S-phase progression
NF-YA depleted cells had a very severe phenotype, with a
strong increase of cell death which is reverted by caspase
inhibition (Figure 2D). Moreover, we highlighted the
presence of non-cycling S cells (S2 fraction), which
increased as apoptosis was suppressed. BrdU incorpor-
ation didn’t raise upon treatment of shNF-YA cells with
ZVAD. On the other hand, the increase of S2 cells
suggests that the main cause of apoptosis activation was
not the inefﬁcient BrdU incorporation, rather the presence
of replicative defects. The analysis of cell cycle progression
in synchronized cells pointed out a delay in completing
DNA replication. BrdU pulse-chase experiment on
synchronized G0 cells clearly identiﬁed a fraction of cells
delayed in clearing S-phase (Figure 3C).
The increase of gH2AX staining in NF-YA inactivated
cells, still detected after apoptosis inhibition, suggests that
DNA-damage occurs upon NF-YA loss. NF-YA deple-
tion could originate spontaneous DSBs in S-phase cells
and NF-Y itself could be fundamental for the intra-S
damage checkpoint. By the analysis of chromatin
enriched extracts, we observed the increase of PCNA
and Mcm7 binding to DNA (Figure 4), which is consistent
with a response to DNA replication defects. In addition to
replication proteins, PCNA interacts with a variety of
proteins involved in DNA-repair, such as nucleases and
polymerases implicated in NER, BER, DSBs repair and
translesion synthesis (43). An excess of Mcm2–7 loading
onto chromatin has been shown to license dormant
origins, in order to maintain DNA replication rates despite
the increased checkpoint activity (38). This pathway has
an important function in maintaining genetic stability in
mammalian cells. The stabilization of p53 protein by the
phosphorylation of Ser15 supports the activation of a
DNA-damage pathway. Moreover, its splice variants
p53, which is recruited to chromatin of NF-YA inacti-
vated cells, is suggestive of the activation of intra-S check-
point. p53 has been shown to bind and transactivate
only p53 target genes involved in cell cycle arrest, such
as p21, indicating a differential transcriptional activity in
damaged S phase cells. Given the increase of apoptosis in
NF-YA inactivated cells, it’s clear that p53 apoptotic tar-
get genes are transactivated too. Indeed, p53 depleted cells
were clearly impaired in apoptosis induction (Figure 4A).
Therefore, we suppose that a complex regulatory network
is involved in controlling S phase progression through
p53; and cell death through phosphorylated p53,
which has also been shown to bind sites of DNA-
damage (44). If the origin of DSBs can delay S-phase pro-
gression or if S-phase accumulated cells are more sensitive
to DNA-damage remains unknown.
Previously, conditional inactivation of NF-YA in
MEFs resulted in the inhibition of S-phase entry and
progression, and ﬁnally led to cell death (24). The effect
of NF-YA inactivation on cell proliferation has been
mainly ascribed to changes in expression of multiple
genes controlling the G1 to S progression (24). GO enrich-
ment analysis of the shNF-YA repressed genes didn’t
identify down-regulation of genes possibly involved in
G1 phase or DNA replication. Conversely, only the cat-
egory of metabolic processes emerged as the statistically
most important terms retrieved. The role of NF-Y in meta-
bolic pathways has been recently identiﬁed (39,45,46).
Genome wide analysis of the occupancy of SREBP1, key
transcriptional regulator of cholesterol and fatty acid me-
tabolism, highlighted that cholesterol biosynthesis, lipid
metabolism and aminoacid activation genes were prefer-
entially regulated by the combination of SREBP1 and
NF-Y binding sites (39). More recently, it has been desc-
ribed that SREBP-2- and NF-Y-mediated regulation of
FDPS gene transcription modulates cell proliferation (40).
NF-YB loss affects G2/M phase progression
The main defect observed in shNF-YB cells was associated
to the prolonged G2/M, which halved the percentage of
cells moving to the next G1 at 20h post-release from
serum starvation (Figure 3). A similar effect was observed
upon the expression of the NF-YA/Bdbd mutant, which
lacks the transcription activation domain but still binds
NF-YB/NF-YC and the CCAAT-box (23). Bdbd expres-
sion inhibited the entry of cells into mitosis and arrested
cells at G2 phase. NF-YB loss doesn’t impair NF-Y
binding as evidently as NF-YA depletion. NF-Y recruit-
ment is reduced but not completely abolished. This reﬂects
the condition induced by NF-YA/Bdbd: NF-Y is still
bound to CCAAT-boxes, but is no more able to activate
the transcription. In particular, the transcription of G2/M
genes is affected by NF-YB loss (Figure 4). The analysis of
microarray data gained by shNF-YB infection perfectly
overlaps with our previous results of siRNA NF-YB
inactivated cells (25). Cell cycle, microtubule/cytoskeleton
and G2/M retrieved categories were expected, given the
established role of NF-Y in controlling cell cycle regulated
genes.
The comparison between NF-YA and NF-YB depletion
strongly highlights that the lack of the single subunits are
differently perceived by the cell, which activate diverse cell
cycle blocks. The loss of NF-YA, which is the only subunit
that can address NF-Y to the CCAAT-box, strongly
affects NF-Y binding, thus leading to no occupancy of
CCAAT boxes. This could induce some type of genome
damage, which may delay cells in completing S phase and
ﬁnally leads to cell death. Conversely, NF-YB depletion
only reduces NF-Y binding to its target genes and the
main consequence observed is the repression of CCAAT
-genes transcription, particularly of G2/M genes, which
show high afﬁnity for NF-Y. Finally, this leads to a
delay in exiting the G2/M phase.
This study suggests a new role of CCAAT-box occu-
pancy by NF-Y beyond its transcriptional activity, which
could play an important function in protecting cells from
DNA damage.
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